Trust Company of Toledo’s Regeneron Pharmaceuticals REGN Stock Holding History

Trust Company of Toledo’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37K	Sell	7 -1	-13%	-$681	﹤0.01%	771
2026 Q1	$6.18K	Buy	8 +1	+14%	+$766	﹤0.01%	679
2025 Q4	$5.4K	Hold	7	–	–	﹤0.01%	655
2025 Q3	$3.94K	Sell	7 -1	-13%	-$565	﹤0.01%	685
2025 Q2	$4.2K	Buy	+8	New	+$4.46K	﹤0.01%	676

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Trust Company of Toledo's REGN Position: Q2 2026 in Review

Trust Company of Toledo reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, selling an estimated $681 and leaving 7 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Trust Company of Toledo first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.18K in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Trust Company of Toledo held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
Trust Company of Toledo sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
Regeneron Pharmaceuticals made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #771 holding.
Trust Company of Toledo first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
Trust Company of Toledo's Regeneron Pharmaceuticals position peaked at $6.18K in Q1 2026.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.